These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3282003)

  • 1. Pharmacological aspects of therapy in inflammatory bowel diseases: antidiarrheal agents.
    Barrett KE; Dharmsathaphorn K
    J Clin Gastroenterol; 1988 Feb; 10(1):57-63. PubMed ID: 3282003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.
    Shah SB; Hanauer SB
    Rev Gastroenterol Disord; 2007; 7 Suppl 3():S3-10. PubMed ID: 18192964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 7: Clinical investigation. Efficacy and safety of loperamide in patients with severe chronic diarrhea.
    Verhaegen H; De Cree J; Schuermans V
    Arzneimittelforschung; 1974 Oct; 24(10):1657-60. PubMed ID: 4611433
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug treatment of inflammatory bowel disease.
    Lennard-Jones JE; Powell-Tuck J
    Clin Gastroenterol; 1979 Jan; 8(1):187-217. PubMed ID: 33775
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs used in treatment of large bowel disease.
    Hilmer R; Goulston K
    Drugs; 1979 Nov; 18(5):403-9. PubMed ID: 116834
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of chronic diarrhea in adults. II].
    Palmas S
    Clin Ter; 1979 Mar; 88(6):639-56. PubMed ID: 380879
    [No Abstract]   [Full Text] [Related]  

  • 7. [Listeria monocytogenes and its relationship with non-biological therapy in inflammatory bowel disease].
    Ontanilla Clavijo G; Trigo Salado C; Leo Carnerero E; de la Cruz Ramírez MD; Araujo Míguez Á; Herrera Justiniano JM; Márquez Galán JL
    Gastroenterol Hepatol; 2015; 38(7):442-3. PubMed ID: 25138387
    [No Abstract]   [Full Text] [Related]  

  • 8. [Opium drops in diarrhea caused by Crohn disease].
    Goerg KJ
    Dtsch Med Wochenschr; 1997 Feb; 122(6):174. PubMed ID: 9081805
    [No Abstract]   [Full Text] [Related]  

  • 9. [Opium drops in diarrhea caused by Crohn disease].
    Ewe K
    Dtsch Med Wochenschr; 1997 Feb; 122(6):174-5. PubMed ID: 9081806
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE DEFEAT OF BONE TISSUE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASES].
    Gabrusskaya TV
    Eksp Klin Gastroenterol; 2016; (2):70-8. PubMed ID: 27301121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug management of inflammatory bowel disease.
    McCarthy CF
    Ir Med J; 1983 May; 76(5):260-2. PubMed ID: 6135675
    [No Abstract]   [Full Text] [Related]  

  • 12. Antidiarrheal Drug Therapy.
    Schiller LR
    Curr Gastroenterol Rep; 2017 May; 19(5):18. PubMed ID: 28397130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic inflammatory bowel diseases. No fear with powerful preventive drugs].
    Rautenstrauch J
    MMW Fortschr Med; 2000 Nov; 142(45):18. PubMed ID: 11107819
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammatory bowel disease: a syllabus of therapy.
    Steinberg H
    Compr Ther; 1978 Sep; 4(9):15-21. PubMed ID: 101331
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic inflammatory bowel diseases. Earlier transition to immunosuppressive drugs].
    Bischoff A
    MMW Fortschr Med; 2002 May; 144(18):10. PubMed ID: 12422699
    [No Abstract]   [Full Text] [Related]  

  • 16. [The clinical and experimental evaluation of the pharmacological efficacy of the new antidiarrheal preparation ftorazol].
    Namitokov KhA; Pak SG; Astashkin EI; Grachev SV; Malova VA
    Ter Arkh; 1997; 69(11):18-21. PubMed ID: 9483738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ulcerative rectocolitis: current clinical and therapeutic concepts].
    Larizza D; Boni R
    Clin Ter; 1982 Nov; 103(3):303-18. PubMed ID: 6129939
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intestinal inflammatory diseases].
    Felley C; Mottet C; Hess J; Juillerat P; Guyot J; Delarive J; Michetti P
    Rev Med Suisse; 2007 Jan; 3(95):201-2, 204-6, 208-14. PubMed ID: 17357689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and safety of rifaximin in children with inflammatory bowel disease.
    Muniyappa P; Gulati R; Mohr F; Hupertz V
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):400-4. PubMed ID: 19668011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Symptomatic antidiarrheal agents].
    Sheptulin AA
    Klin Med (Mosk); 1999; 77(5):45-8. PubMed ID: 10394787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.